Market Place
Sourcing Support
Myeloid Posters At ASGCT 2024 Annual Meeting
07 May 2024 //
PR NEWSWIRE
Prime Medicine and Myeloid Announce Settlement of Pending Disputes
05 Jan 2024 //
PR NEWSWIRE
Myeloid Announces Appointment of Matthew Maurer, M.D. as Chief Medical Officer
06 Dec 2023 //
PR NEWSWIRE
Myeloid Therapeutics to Participate at SVB Company Connect Event
23 May 2023 //
PR NEWSWIRE
Myeloid Therapeutics Gets $73M Financing for mRNA-based Immunotherapy Pipeline
19 May 2023 //
CONTRACT PHARMA
Myeloid raises $73M, bringing in ARCH ahead of in vivo program
18 May 2023 //
ENDPTS
Myeloid goes down under for new manufacturing site, with $66M local investment
21 Feb 2023 //
ENDPTS
Myeloid to Present at the Guggenheim Healthcare Talks 2023 Oncology Day
31 Jan 2023 //
PR NEWSWIRE
Myeloid Therapeutics Announces FDA Fast Track Designation for MT-101
27 Oct 2022 //
PRNEWSWIRE
Myeloid Therapeutics Partners with Acuitas Therapeutics for LNP System
19 May 2022 //
PRNEWSWIRE
Myeloid Therapeutics Doses First Patient with MT-101 in PI/II Study
11 May 2022 //
PRNEWSWIRE
Myeloid Tx Presents Late-Breaking Data at AACR 2022
10 Apr 2022 //
PRNEWSWIRE
Newpath en route to backing a host of biotechs with $350M 2nd fund
08 Dec 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.